As of 2025-05-29, the Gross Margin of Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS) is 52.4%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 52.4% |
2023-12-31 | 57.9% |
2022-12-31 | 58.8% |
2021-12-31 | 60% |
2020-12-31 | 64.6% |
2019-12-31 | 74.4% |
2018-12-31 | 75.9% |
2017-12-31 | 72.4% |
2016-12-31 | 47.5% |
2015-12-31 | 53.2% |